| Unique ID issued by UMIN | UMIN000054363 |
|---|---|
| Receipt number | R000062076 |
| Scientific Title | The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy |
| Date of disclosure of the study information | 2024/05/31 |
| Last modified on | 2025/04/02 16:32:03 |
The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy
The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy
The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy
The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy
| Japan |
Healthy adults
| Not applicable | Adult |
Others
NO
To assess the effect of lactic acid bacteria ingestion during 12 weeks of resistance training on muscle hypertrophy
Efficacy
Confirmatory
Skeletal muscle mass
Body composition
Abdominal visceral fat mass
Inflammation-related biomarkers
Intestinal flora
Muscle soreness
Safety assessment
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
3
Treatment
| Food |
Resistance training (2 times per week)
Ingestion of low dose lactic acid bacteria powder, twice per day, 12 weeks
Resistance training (2 times per week)
Ingestion of high dose lactic acid bacteria powder, twice per day, 12 weeks
Resistance training (2 times per week)
Ingestion of placebo powder, twice per day, 12 weeks
| 30 | years-old | <= |
| 60 | years-old | > |
Male
1.Subjects who can give informed consent to participate in this study
2.Males aged 30 to 59 years old
3.Subjects who perform exercises at least once a month
1. Subjects who have a chronic medical condition undergoing treatment, or who have a history of a serious illness
2. Subjects who have a disease that causes temporary muscle spasms or loss of consciousness
3. Subjects who have significant orthopedic injuries
4. Subjects who restricted exercise or bathing due to medical reasons
5. Subjects who are allergic to milk, wheat, orange, beef, sesame, soy, chicken, banana, apple, or gelatin
6. Subjects who use drugs that may affect the results of the study
7. BMI<18.5, BMI>=30
8. Smoker
9. Heavy drinkers
10. Subjects who perform resistance training using barbells, dumbbells or machines at least once a week
11. Subjects who participate other clinical studies
12. Subjects who are judged as unsuitable for the study by the principal investigator for other reason
36
| 1st name | Chiaki |
| Middle name | |
| Last name | Sanbongi |
Meiji Co., Ltd.
R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo, Japan
+81-42-632-5847
chiaki.sanbongi@meiji.com
| 1st name | Aya |
| Middle name | |
| Last name | Yoshimura |
Meiji Co., Ltd.
R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo, Japan
+81-42-632-5847
aya.yoshimura.aa@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
Ritsumeikan University
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F, Daiwa Bldg.3-3-10 Nihonbashi Hongokucho, Chuo-ku, Tokyo, Japan
+81-3-6225-9005
IRB@cpcc.co.jp
YES
MIJ24C4
CPCC Company Limited
株式会社 明治 研究本部
(R&D Division, Meiji Co., Ltd.)
| 2024 | Year | 05 | Month | 31 | Day |
Unpublished
No longer recruiting
| 2024 | Year | 04 | Month | 22 | Day |
| 2024 | Year | 04 | Month | 19 | Day |
| 2024 | Year | 06 | Month | 09 | Day |
| 2024 | Year | 11 | Month | 20 | Day |
| 2024 | Year | 05 | Month | 10 | Day |
| 2025 | Year | 04 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062076